-
Mashup Score: 5
Here, we summarize a post hoc analysis investigating the effects of refractoriness to standard-dose prior alkylators on the effectiveness of melflufen + dexamethasone on a subset of patients enrolled in the OCEAN trial.
Source: multiplemyelomahub.comCategories: General Medicine News, Onc News and JournalsTweet
Is the effectiveness of melflufen altered in patients with #MultipleMyeloma and who are refractory to prior alkylators? Read our summary of a post hoc analysis of the phase III OCEAN trial to learn more: https://t.co/SxmLESjJO0 #myeloma #mmsm #MedicalEducation https://t.co/f08N1mPa5x